CHRISTINA RAY: Open Payments
NPI 1851988828 · ALABASTER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,154 in 181 payments from 21 companies in 2025. Trend: 2023 $3,206 · 2024 $4,138 · 2025 $4,154
Food & beverage: $4,154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $820 |
| Ardelyx, Inc. | 22 | $512 |
| Janssen Biotech, Inc. | 17 | $511 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $308 |
| Lilly USA, LLC | 6 | $219 |
| QOL Medical, LLC | 8 | $205 |
| Aimmune Therapeutics, Inc. | 12 | $197 |
| GENZYME CORPORATION | 8 | $191 |
| Madrigal Pharmaceuticals | 6 | $168 |
| Phathom Pharmaceuticals, Inc. | 10 | $157 |
Products named: TREMFYA, IBSRELA, DUPIXENT, RINVOQ, ENTYVIO, CREON, Sucraid, ZENPEP.
Industry payments across AL — which companies pay providers there.
